Subsequent Events	12 Months Ended
Dec. 31, 2013
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Business Acquisition Effective January 27, 2014 Ebix acquired the entire business of CurePet in an asset purchase agreement with the total purchase consideration being in the amount of $6.35 million which includes a possible contingent earnout payment of up to $5.0 million based on earned revenues over the subsequent thirty-six month period following the date of the acquisition. Previously and as discussed in Note 19 "Minority Business Investment" during 2012, Ebix acquired a minority 19.8% interest in CurePet, Inc. ("CurePet") for cash consideration in the amount of $2.0 million. CurePet is a business that has completed an insurance exchange that connects pet owners, referring veterinarians, animal hospitals, academic institutes, and suppliers of medical and general pet supplies, while providing a wide variety of services related to pet insurance to each constituent including practice management, electronic medical records, and billing. Dividends As announced on February 5, 2014, the Company resumed its quarterly cash dividend to the holders of its common stock, whereby a dividend in the amount of $0.075 per common share will be paid March 14, 2014 to shareholders of record on February 20, 2014. Repurchases of Common Stock Since December 31, 2013 and through March 17, 2014 the Company has purchased an additional 137,071 shares of its outstanding common stock for aggregate consideration in the amount of $2.23 million. All share repurchases were done in accordance with Rule 10b-18 of the Securities Act of 1934 as to the timing, pricing, and volume of such transactions, and were completed using available cash resources and cash generated from the Company's operating activities. Shareholder Securities Class Action Settlement On March 7, 2014 the Company remitted $4.2 million to the requisite escrow agent in compliance with the settlement agreement in the shareholder securities class action styled In re: Ebix, Inc. Securities Litigation, Civil Action No. 1:11-CV-02400-RWS (N.D. Ga.).

Subsequent Events

Business Acquisition

Effective January 27, 2014 Ebix acquired the entire business of CurePet in an asset purchase agreement with the total purchase consideration being in the amount of $6.35 million which includes a possible contingent earnout payment of up to $5.0 million based on earned revenues over the subsequent thirty-six month period following the date of the acquisition. Previously and as discussed in Note 19 "Minority Business Investment" during 2012, Ebix acquired a minority 19.8% interest in CurePet, Inc. ("CurePet") for cash consideration in the amount of $2.0 million. CurePet is a business that has completed an insurance exchange that connects pet owners, referring veterinarians, animal hospitals, academic institutes, and suppliers of medical and general pet supplies, while providing a wide variety of services related to pet insurance to each constituent including practice management, electronic medical records, and billing.

Dividends

As announced on February 5, 2014, the Company resumed its quarterly cash dividend to the holders of its common stock, whereby a dividend in the amount of $0.075 per common share will be paid March 14, 2014 to shareholders of record on February 20, 2014.

Repurchases of Common Stock

Since December 31, 2013 and through March 17, 2014 the Company has purchased an additional 137,071 shares of its outstanding common stock for aggregate consideration in the amount of $2.23 million. All share repurchases were done in accordance with Rule 10b-18 of the Securities Act of 1934 as to the timing, pricing, and volume of such transactions, and were completed using available cash resources and cash generated from the Company's operating activities.

Shareholder Securities Class Action Settlement

On March 7, 2014 the Company remitted $4.2 million to the requisite escrow agent in compliance with the settlement agreement in the shareholder securities class action styled In re: Ebix, Inc. Securities Litigation, Civil Action No. 1:11-CV-02400-RWS (N.D. Ga.).